Home/Filings/4/0001181431-14-005500
4//SEC Filing

BG Medicine, Inc. 4

Accession 0001181431-14-005500

CIK 0001407038operating

Filed

Feb 5, 7:00 PM ET

Accepted

Feb 6, 4:32 PM ET

Size

7.4 KB

Accession

0001181431-14-005500

Insider Transaction Report

Form 4
Period: 2014-02-04
Adourian Aram S.
VP, Scientific Affairs
Transactions
  • Award

    Stock Option (right to buy)

    2014-02-04+50,00050,000 total
    Exercise: $1.15Exp: 2024-02-04Common Stock (50,000 underlying)
  • Award

    Stock Option (right to buy)

    2014-02-04+93,00093,000 total
    Exercise: $1.15Exp: 2024-02-04Common Stock (93,000 underlying)
Footnotes (2)
  • [F1]The option vests as to 25% of the shares on February 4, 2015 and vests as to an additional 6.25% of the shares per quarter thereafter until February 4, 2018.
  • [F2]The option vests as to 50% of the shares on February 4, 2015 and vests as to the remaining 50% of the shares on February 4, 2016.

Issuer

BG Medicine, Inc.

CIK 0001407038

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001407038

Filing Metadata

Form type
4
Filed
Feb 5, 7:00 PM ET
Accepted
Feb 6, 4:32 PM ET
Size
7.4 KB